Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 18, 2022

SELL
$6.87 - $11.11 $428,509 - $692,975
-62,374 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $480,279 - $2.32 Million
62,374 New
62,374 $609,000
Q2 2021

Aug 16, 2021

SELL
$32.73 - $47.95 $670,964 - $982,975
-20,500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$40.39 - $56.73 $827,995 - $1.16 Million
20,500 New
20,500 $920,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.